SCHEMBL19377186

SCHEMBL19377186

CC(NC(=O)Nc1ccc(S(=O)(=O)Cc2ccc3c(c2)CCN(C)C3)cc1)c1cccc(Cl)c1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ROCK2 O75116 4/20 0.43
▸ GHSR Q92847 1/20 0.41
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ USP2 O75604 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ MLNR O43193 2/20 0.38
▸ HTT P42858 1/20 0.37
▸ DRD2 P14416 3/20 0.37
▸ DRD3 P35462 3/20 0.37
▸ LMNA P02545 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ RORC P51449 2/20 0.37
▸ ACACB O00763 2/20 0.36
▸ CYP1A2 P05177 2/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ CYP2D6 P10635 2/20 0.36
▸ CYP2C9 P11712 2/20 0.36
▸ HTR2A P28223 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19377340 1.00 ROCK2 (0.43) ROCK2GHSRMEN1KMT2AUSP2
SCHEMBL19377185 1.00 ROCK2 (0.43) ROCK2GHSRMEN1KMT2AUSP2
SCHEMBL19377308 0.94 ROCK2 (0.43) ROCK2MEN1KMT2AUSP2GAA
SCHEMBL24800429 0.93 ROCK2 (0.43) ROCK2MEN1KMT2AUSP2GAA
SCHEMBL19377057 0.91 KCNA1 (0.38) ROCK2GHSRMEN1KMT2AUSP2
SCHEMBL19398854 0.90 NPC1 (0.42) MEN1KMT2AMAPTMLNRLMNA
SCHEMBL19377138 0.89 ABCB1 (0.45) MEN1KMT2AMAPTHTTLMNA
SCHEMBL19377139 0.89 ABCB1 (0.45) MEN1KMT2AMAPTHTTLMNA
SCHEMBL24800636 0.88 ROCK2 (0.44) ROCK2MEN1KMT2AUSP2MAPT
SCHEMBL19398856 0.88 KCNA1 (0.38) GHSRMEN1KMT2AMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3390355-B1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2022-12-28 — — EP claimed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US claimed
EP-3390355-B1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2022-12-28 — — EP disclosed
EP-3390355-B1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2022-12-28 — — EP disclosed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof UTS2R, GHSR, GRPR ROCK2 4208/4885GHSR 2/4885MEN1 3276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback